IP Library Patent Application 18437722
Patent Application
App. No. 18/437,722

POLYMER COATING FOR MEDICAL DEVICES AND METHOD OF MANUFACTURE THEREOF

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/437,722
Abstract

Disclosed herein is a bio-resistant article comprising a porous metal substrate; a self-assembled monolayer disposed on the substrate; wherein the self-assembled monolayer comprises a coupling agent that has a first end that is reactively bonded to the porous metal substrate and a second end that is reactively bonded to a zwitterionic polymer. Disclosed herein too is a method comprising disposing upon a porous metal substrate a self-assembled monolayer; and bonding the zwitterionic polymer to the self-assembled monolayer.

Claims (29)

1 . A bio-resistant article comprising:

a porous metal substrate;

a self-assembled monolayer disposed on the substrate; wherein the self-assembled monolayer comprises a coupling agent that has a first end that is reactively bonded to the porous metal substrate and a second end that is reactively bonded to a zwitterionic polymer,

wherein the bio-resistant article is a biomedical implant or drug delivery device.

2 . The bio-resistant article of claim 1 , wherein the porous metal surface comprises a metal; wherein the metal comprises iron, zinc, magnesium, aluminum, gold, platinum, stainless steel, titanium, tantalum, iridium, molybdenum, niobium, palladium, chromium, or alloys thereof.

3 . The bio-resistant article of claim 1 , wherein the porous metal surface comprises a metal; wherein the metal comprises iron, zinc, magnesium, aluminum, platinum, stainless steel, titanium, tantalum, iridium, molybdenum, niobium, palladium, chromium, or alloys thereof.

4 . The bio-resistant article of claim 1 , wherein the porous metal surface has an average pore diameter of about 10 nanometers to about 100 micrometers.

5 . The bio-resistant article of claim 4 , wherein the porous metal surface has an average pore diameter of about 100 nanometers to about 1 micrometer.

6 . The bio-resistant article of claim 1 , wherein the porous metal surface comprises a metal oxide; wherein the metal oxide comprises tantalum oxide, titanium oxide, iridium oxide, niobium oxide, zirconium oxide, tungsten oxide, rhodium oxide, or a combination thereof.

7 . The bio-resistant article of claim 1 , wherein the first end comprises a first reactive functionality that comprises a silane, a thiol, a carboxyl, an amide, an imide, an ester, a sulfate ester, a phosphate ester, a thiophosphate ester, a borate ester, a urea, an epoxide, a carbamate, a thiocarbamate, a thiosulfate, a sulfonate, a phosphonate, a halogen thiophosphonate, a nitro, a nitroso, a nitrate, a nitrite, or a combination thereof.

8 . The bio-resistant article of claim 1 , wherein the zwitterionic polymer is polymerized from a monomer by a reactive initiator located at the second end of the coupling agent.

9 . The bio-resistant article of claim 1 , wherein the zwitterionic polymer is polyphosphorylcholine, polysulfobetaine, polycarboxybetaine, polytrimethylamine N-oxide, or a combination thereof.

10 . The bio-resistant article of claim 1 , wherein the zwitterionic polymer is polytrimethylamine N-oxide.

11 . The bio-resistant article of claim 10 , wherein the zwitterionic polymer forms a layer that is less than 1000 nanometers thick.

12 . The bio-resistant article of claim 1 , wherein the bio-resistant article is a drug delivery device.

13 . The bio-resistant article of claim 1 , wherein the bio-resistant article is a biomedical implant.

14 . The bio-resistant article of claim 3 , wherein the bio-resistant article is a drug delivery device.

15 . The bio-resistant article of claim 3 , wherein the bio-resistant article is a biomedical implant.

16 . A method for fabricating an article, comprising:

disposing upon a porous metal substrate a self-assembled monolayer; and

bonding a zwitterionic polymer to the self-assembled monolayer,

wherein the article is a biomedical implant or drug delivery device.

17 . The method of claim 16 , further comprising reactively bonding the self-assembled monolayer to the substrate.

18 . The method of claim 17 , further comprising initiating polymerization of the zwitterionic polymer via a reactive initiating functionality disposed on an end of the self-assembled monolayer.

19 . A bio-resistant article comprising:

a porous metal substrate;

a self-assembled monolayer disposed on the substrate; wherein the self-assembled monolayer comprises a coupling agent that has a first end that is reactively bonded to the porous metal substrate and a second end that is reactively bonded to a zwitterionic polymer,

wherein the porous metal surface comprises a metal; wherein the metal comprises iron, zinc, magnesium, aluminum, platinum, stainless steel, titanium, tantalum, iridium, molybdenum, niobium, palladium, chromium, or alloys thereof.

20 . The bio-resistant article of claim 19 , wherein the bio-resistant article is a blood contacted sensor.

Assignments (3)
SECURITY INTEREST Recorded Oct 14, 2025
From: PNC BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
To: MOTT CORPORATION; DIGESTED ORGANICS LLC
Reel/Frame 072559/0785 →
SECURITY INTEREST Recorded Apr 18, 2024
From: MOTT CORPORATION; DIGESTED ORGANICS LLC
To: PNC BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
Reel/Frame 067162/0539 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 9, 2024
From: HILL, ALEX
To: MOTT CORPORATION
Reel/Frame 066431/0089 →